Adopting an AI-forward approach to the R&D IT ecosystem means moving beyond experimentation to embedding AI into core business processes across safety, regulatory, quality, and medical affairs.
Real-world impact depends on more than deploying models—it requires integration into workflows, data harmonization, and user trust. A platform-first approach, underpinned by strong data governance and cloud scalability, ensures AI becomes a true co-pilot across functions. As pharma companies evolve toward digital maturity, operationalizing AI across the R&D value chain will be a critical lever for speed, compliance, and innovation.
Reasons to Attend
Featured Speakers

Denny Lorenz
Managing Director and Principal Consultant
Lorenz Bratti GmbH

Myra Abousabe
Exec. Dir, Strategy & Application Operations, Drug Development IT
Bristol Myers Squibb

Bina Patel
AVP, Pharmacovigilance Operations
Amgen

Raj Ratwani
VP of Scientific Affairs & Director, National Center for Human Factors
MedStar Health Research Institute

Sam Wallis
Head of Case Management, Patient Safety
Bristol Myers Squibb

Michael Murphy
Senior Vice President, Head of Regulatory Affairs and PV Operations
Astellas

Julie Thomas
Vice President, Global Medical Safety Operations
Johnson & Johnson

Felix Arellano
Global Head of Pharmacovigilance
Roche

Marta Higuera
AI Labs Director
Insud Pharma

Michael Sonntag
Director Global Regulatory Affairs & Pharmacovigilance
Worwag

Fabrice Besle
Head of Technology and Digital, Patient Safety
Ipsen

Mariette Boerstoel
Senior Vice President, Worldwide Patient Safety Officer
Bristol Myers Squibb

Claudia Schaffer
Head of ICSR Management
Merck KGaA

Frits Stulp
Partner – Life Sciences
Implement Consulting Group

Griselda Saldana
Senior Director, Global Safety
Amgen

Ellen Mishalov
Executive Director, Head of PV Transformation and Technology
Astellas

Attila Olah
Head of Global Patient Safety
Gedeon Richter

Claudia Lehmann
Head of Global Pharmacovigilance Operations
Boehringer Ingelheim

Andrea Rogers
Executive Director, R&D Informatics
Amgen

Preeya Beczek
Regulatory Affairs and Compliance – Director and Co-founder
BECZEK.COM

Steve Gens
Managing Partner
Gens & Associates

Yvonne Schäfer
Head of PSPV Systems Business Solutions
Boehringer Ingelheim

Amrit Gill
Global Head of Safety (PV)
Opella

Remco Munnik
Owner & Founder
Arcana

Sandeepa Raina
Senior Director, IT Business Partner, Worldwide Patient Safety – R&D Informatics
Bristol Myers Squibb

Spencer Michelson
Director
Nordic Capital

Aman Wasan
Chief Executive Officer
ArisGlobal

Lucinda Smith
Chief Safety Product Officer
ArisGlobal

Jason Bryant
General Manager, NavaX
ArisGlobal
More to be announced
Hear from Our Attendees
“One of the best conferences with meaningful information“
Worldwide Patient Safety Officer
“The overall energy was very powerful—the perfect opportunity to meet our vendors in person, connect beyond the screens, collaborate with peers, learn from leading pharma companies, and gain new ideas.”
Global Head of Regulatory Operations
“Great opportunity to learn, network with a variety of people and have good ideas and experiences under one roof. The opportunity to listen, ask questions and seek advice from people was really great.”
Head Global PV Operations
Discussions you won’t want to miss
Travel & Info
VENUE
We are thrilled to bring Breakthrough 2026 to
Madrid, Spain on February 10-11.
The Palace
Pl. de las Cortes,
7, Centro, 28014 Madrid, Spain
Enjoy a special group rate at The Palace, complete with breakfast, flexible booking, and loyalty point eligibility.
Additional nearby hotels:
*Please note: Whilst ArisGlobal recommends these hotels no room block has been secured


About
Breakthrough 2026 is ArisGlobal’s annual flagship event, bringing together life sciences leaders, pharmaceutical innovators, and regulatory authorities.
Join us for keynotes, panels, and networking sessions that explore how PV and Regulatory teams are making AI a core part of daily operations.
Experience live demos of LifeSphere and LifeSphere NavaX in the Innovation Center, and connect with ArisGlobal’s partners through our open ecosystem.
ArisGlobal reserves the right to deny registrants upon review.

